Home | Welcome to Contract Pharma   
Last Updated Sunday, April 20 2014
Print

Topics - Biologics, Proteins, Vaccines


Refine by Date:
From: To:
Published April 9, 2014
Shows partnership activity up 34% in 2013 Read More »
Published April 4, 2014
Will be used to enhance infectious disease development program Read More »
Published April 4, 2014
Will provide testing services for Raptor’s trial in Leigh syndrome Read More »
Published April 3, 2014
Launches QIAxpert instrument and CLC Cancer Research Workbench Read More »
Published April 2, 2014
Bio-analytical testing and genomic services becomes Eurofins Genomics Read More »
By Kristin Brooks
Published March 26, 2014
Will use NanoStat platform for RSV and flu vaccine development Read More »
By Kristin Brooks
Published March 25, 2014
To manufacture ADC candidate for Phase I trials Read More »
By Kristin Brooks
Published March 25, 2014
To provide additional cGMP manufacturing services to support Phase II trials of NEO-102 Read More »
By Kristin Brooks
Published March 24, 2014
SMARTag ADC Technology achieves key milestone Read More »
By Kristin Brooks
Published March 21, 2014
Will use POTELLIGENT CHOK1SV for antibody development Read More »
By Kristin Brooks
Published March 21, 2014
Adds biopharma assessment services Read More »
By Kristin Brooks
Published March 12, 2014
To support factor VIII (rFVIII) hemophilia products in Phase III development Read More »
By Kristin Brooks
Published March 6, 2014
Will produce PLacental eXpanded (PLX) cell products Read More »
By Kristin Brooks
Published March 5, 2014
To develop a vaccine to treat botulism Read More »
By Kristin Brooks
Published March 4, 2014
Will use the technology to enhance the ADCC activity lead product Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On